Article

Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.

Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery (impact factor: 2.92). 02/2012; 43(2):198-207. DOI:10.1016/j.ejvs.2011.09.016 pp.198-207
Source: PubMed

ABSTRACT To obtain Western European perspectives on the economic burden of atherothrombosis in patients with multiple risk factors only (MRF), cerebrovascular disease (CVD), coronary artery disease (CAD), and in the under-evaluated group of patients with peripheral arterial disease (PAD), we examined vascular-related hospitalisation rates and associated costs in France and Germany.
The prospective REACH Registry enrolled 4693 patients in France, and 5594 patients in Germany (from December 2003 until June 2004).
For each country, 2-year rates and costs associated with cardiovascular events and vascular-related hospitalisations were examined for patients with MRF, CVD, CAD, and PAD.
Two-year hospitalisation costs were highest for patients with PAD (3182.1€ for France; 2724.4€ for Germany) and lowest for the MRF group (749.1€ for France; 503.3€ for Germany). Peripheral revascularizations and amputations were the greatest contributors to costs for all risk groups. Across all PAD subgroups, peripheral procedures constituted approximately half of the 2-year costs.
Hospitalisation rates and costs associated with atherothrombotic disease in France and Germany are high, especially so for patients with PAD.

0 0
 · 
0 Bookmarks
 · 
48 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

2-year costs
 
2-year rates
 
atherothrombotic disease
 
cerebrovascular disease
 
coronary artery disease
 
economic burden
 
greatest contributors
 
Hospitalisation rates
 
MRF group
 
multiple risk factors
 
PAD subgroups
 
peripheral arterial disease
 
peripheral procedures constituted
 
Peripheral revascularizations
 
prospective REACH Registry
 
risk groups
 
Two-year hospitalisation costs
 
vascular-related hospitalisation rates
 
vascular-related hospitalisations
 
Western European perspectives